Background: This study aimed to examine whether the combination of low-dose ketamine and propofol in deep sedation is clinically useful in controlling the behavior in intellectually disabled patients who are typically extremely noncooperative during dental procedures. Methods: A total of 107 extremely noncooperative intellectually disabled adult patients were analyzed. In all patients, deep sedation was performed using either propofol alone (group P) or using a combination of propofol and 0.2 mg/kg or 0.4 mg/kg ketamine (groups PK0.2 and PK0.4, respectively). The procedures were performed in the order of insertion of nasal cannula into the nostril, attachment of mouth gag, and mouth cleaning and scaling. The frequency of patient movement during the procedures, mean arterial pressure, heart rate, peripheral oxygen saturation, recovery time, discharge time, and postoperative nausea and vomiting were examined. Results: The three groups were significantly different only in the frequency of patient movement upon stimulation during single intravenous injection of propofol and scaling. Conclusion: For propofol deep sedation, in contrast to intravenous injection of propofol alone, prior intravenous injection of low-dose ketamine (0.4 mg/kg) is clinically useful because it neither affects recovery, nor causes side effects and can suppress patient movement and vascular pain during procedures.
INTRODUCTION
Due to the challenge in gaining the cooperation of intellectually disabled patients when performing dental procedures, behavior control using drugs, such as intravenous moderate sedation, deep sedation, and intubated general anesthesia, is often required [1, 2] .
Among these, in cases in which behavior control poses a significant challenge, unconscious sedation, namely, deep sedation or intubated general anesthesia, becomes necessary. For follow-ups and mouth cleaning of extremely noncooperative intellectually disabled patients who have undergone multiple teeth intensive treatment under intubated general anesthesia, unconscious sedation is necessary, even in short procedures; in this case, deep sedation is often performed.
Drugs used for deep sedation in outpatients undergoing day surgery must have certain properties, including rapid onset of action and ability to provide adequate patient movement suppression during procedures. Moreover, good recovery must be ensured, including minimal respiratory and circulatory depression, short time to awakening, and absence of postoperative discomfort.
Propofol, which activates inhibitory GABA receptors, allows rapid recovery and is considered suitable for deep sedation in outpatients undergoing day surgery [3, 4] .
However, this drug has a few drawbacks including the possibility of patient movement in the middle of a procedure and vascular pain at the time of administration because it has no analgesic effect. Furthermore, it may cause respiratory or circulatory depression due to sympathoinhibition [5] . In contrast to propofol, ketamine, which competes with excitatory NMDA receptors, possesses the property of maintaining an analgesic and sympathomimetic effect and airway reflex [6] . Additionally, prior administration of ketamine is reported to relieve vascular pain that occurs during propofol administration [7, 8] .
Nevertheless, ketamine also has drawbacks, including the possibility of postoperative hallucination and vomiting [9] . In contrast, propofol acts to suppress postoperative vomiting and prevent nightmares caused by ketamine [3, 4] . Therefore, to compensate for the shortcomings of these two drugs, deep sedation using a combination of propofol and ketamine has been adopted in examinations, emergency medical care, and minor surgeries in outpatients. However, in most cases, midazolam and fentanyl are used simultaneously [10] [11] [12] . There are few reports addressing the use of deep sedation via intravenous anesthesia, using only propofol and ketamine in dental treatments. For extremely noncooperative intellectually disabled patients who have undergone multiple teeth intensive treatment under intubated general anesthesia, deep sedation using a combination of propofol and low-dose ketamine has been adopted at the Chiba City Health and Medical Center (Chiba, Japan) during mouth cleaning and scaling in regular follow-ups, a few months after the intensive treatment.
We conducted a retrospective study to examine whether prior injection of low-dose ketamine during propofol deep sedation, compared with injection of propofol alone, was able to suppress patient movement during treatments and mitigate vascular pain. Moreover, we also assessed whether it is able to prevent respiratory and circulatory depression caused by propofol, exerts effects on patient recovery, or causes side effects such as postoperative vomiting. In other words, we examined whether the combination of low-dose ketamine and propofol in deep sedation is clinically useful in controlling behavior in intellectually disabled patients who are typically extremely noncooperative during dental procedures.
MATERIALS AND METHODS
This study was conducted after obtaining approval from the Ethics Committee of Tokyo Dental College (Table 1) , which indicates the magnitude of escape behaviors.
Statistical analysis
Statistical analysis was performed using nonrepeated measures ANOVA for intergroup comparisons of sex, Additionally, the intergroup comparisons of the frequency of number of cases with additional propofol injection and the frequency of patient movement during procedures were performed using the m × n chi-squared test.
Differences with a P-value < 0.05 were considered statistically significant.
RESULTS
There was no significant difference in age, weight, sex ratio, duration of procedure, time to eye opening, total
propofol dose, frequency of number of cases with additional propofol injection, and time to discharge in the 3 groups (Table 2 ).
There was a significant difference only in frequency of patient movement upon stimulation during single intravenous injection of propofol and scaling in the 3 groups ( Table 3 profiles during the procedures (Table 2 ). There was no in all 3 groups, time-dependent changes in MABP during the procedures were not significant, and there was no significant difference in the 3 groups at all time points. Fig. 3 . Changes in heart rate (HR) during procedures: in all 3 groups, time-dependent changes in HR during the procedures were not significant, and there was no significant difference in the 3 groups at all time points.
significant difference in the frequency of postoperative vomiting in the 3 groups (Table 2) , and no abnormal behaviors after anesthesia were observed (Table 2) . Deep sedation with propofol, in place of traditionally used barbiturate(s), has become the preferred anesthetic method for dentoalveolar surgery and office oral and maxillofacial anesthesia [16] . The recommended administration method begins with induction through a bolus injection of 1 mg/kg, followed by maintenance through continuous injection at a rate of 4-6 mg/kg/h [17] . Because the subjects in this study were intellectually disabled and extremely noncooperative, and reliable patient-movement control was necessary, anesthesia was performed through induction using a bolus injection of [21] . Furthermore, ketamine dissociates within 1-2 min after intravenous injection, and the effect is maintained for 10-15 min [22] . Therefore, it is believed that the addition of a small amount of ketamine to propofol anesthesia through this method deepens anesthesia and is useful in suppressing patient movement.
Propofol may cause vascular pain when intravenously injected, with the frequency reported to be 28-90% [23] in adults under anesthetic induction and 33-50% [24] when a small amount of necessary propofol is injected for sedation. In the present study, withdrawal reflex involving the hand or arm, presumed to be caused by vascular pain, was observed in 25.7% of patients in group P. Although several methods to reduce the frequency and magnitude of vascular pain, such as the addition of lidocaine, have been reported, the addition of ketamine is also an option. It has been reported that the injection of ketamine 0.1-0.15 mg/kg before intravenous injection of propofol could reduce vascular pain caused by propofol from 84% to 26% [7] or from 86.7% to 46.7% [8] . In our study, patient movement was observed in 5.8% of patients in group PK0.2, but none in Group PK0.4, indicating that ketamine contributed to the prevention of vascular pain during intravenous propofol injection.
Some drawbacks of propofol include the relatively higher incidence of dose-dependent hypotension and respiratory depression. Hypotension due to propofol has been reported to be caused by a decrease in systemic vascular resistance and direct myocardial depression [25] .
It has also been reported that by simply adding ketamine 0.5 mg/kg, which has a sympathomimetic effect, before the intravenous injection of propofol, hemodynamics during procedures can be maintained at levels comparable with those during control [26] . The cases in this study were different from those in previous studies in that MBP and HR in group P and groups PK0.2 and PK0.4 tended to decrease over time when compared with those in the control. However, the changes were not significant, and there were no differences among the 3 groups at all time points of measurement. Because MBP in the PK groups did not increase dose-dependently, the intravenous injection with low-dose ketamine < 0.4 mg/kg may not have affected the circulatory system. Propofol has been reported to cause respiratory depression through the depression of the inspiratory center by decreasing the ratio of tidal volume to inspiratory time [27] . According to clinical research performed in emergency medical care settings, compared with propofol alone, the combination of propofol and ketamine could reduce respiratory depression [28] . In the present study, SpO 2 decreased to < 95% in 27% of patients in group P and approximately 16% in the PK groups; however, there was no statistically significant difference between the two groups, and all incidences of SpO 2 reduction were resolved through jaw-lift. Thus, the reduction is believed to be caused by transient airway obstruction due to glossoptosis. In this study, clinically problematic circulatory depression and respiratory depression were not observed in group P and there was no difference when compared with both the PK groups. In other words, the addition of low-dose ketamine < 0.4 mg/kg in propofol anesthesia was considered to have no effect on the circulatory and respiratory systems.
Complications of deep sedation with propofol-ketamine combination include vomiting and mental abnormalities, including hallucination. Although propofol has demonstrated an anti-nausea effect through dopamine D 2 receptor antagonism, it is reported that the frequency of nausea after propofol-ketamine anesthesia increases as the ketamine dose increases [29] . Although vomiting was not noted in group PK0.2 in the present study, it was observed in 1 of 38 patients in group PK0.4; however, it is unclear whether it was caused by ketamine. It has been reported that mental abnormalities due to ketamine intravenous injection are not observed when the dose is < 1 mg/kg [30] ; however, a previous study reported that 10% of patients experienced hallucinations after sedation with propofol-ketamine 0.1 mg/kg [31] . In this study, such abnormal behaviors were not observed.
In 
